The study, titled “The Effects of Oral Ibuprofen and Celecoxib in Preventing Pain, Improving Recovery Outcomes and Patient Satisfaction After Ambulatory Surgery,” looked at 180 patients undergoing outpatient surgery. The patients were assigned to three treatment groups and given either a placebo drug, celecoxib or ibuprofen. The researchers then looked at recovery times and postoperative pain scores and assessed post-discharge pain and other factors 24 hours, 48 hours, 72 hours, seven days and 30 days after surgery.
Quality of recovery scores and patient satisfaction with postoperative pain management were improved in the celecoxib and ibuprofen groups compared with the control group.
Read the abstract of the study in Anesthesia & Analgesia.
Read more on anesthesia:
–Hand Contamination of Anesthesia Providers Leads to Surgical Bacteria Transmission
–Injecting Botox Into Spine Could Relieve Pain
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.